ReviewEuropean journal of clinical pharmacology2023

Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype.

Birgit M Wollmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.